Patrones de tratamiento biológico en pacientes con enfermedades articulares inflamatorias. Estudio retrospectivo de 4 años de seguimiento Juan D. Cañete; Antonio Naranjo; Javier Calvo; Carmen Ordás; Belén Aragón; Gonzalo Nocea; Montse Roset; Antonio Fernández-Nebro;

Ranking the importance of their own diseases: A positioning analysis in rheumatic patients and their proxies Aldo Barajas-Ochoa; Elias Kaleb Rojero-Gil; Lilia Patricia Bustamante Montes; Cesar Ramos-Remus;

Is the use of secukinumab after anti-TNF therapy greater than expected for the risk of developing inflammatory bowel disease? Fatih Albayrak; Mustafa Gür; Ahmet Karata¿; Süleyman Serdar Koca; Bünyamin K¿sac¿k;